Portland-based animal-health company Covetrus Inc. (Nasdaq: CVET) on Thursday reported financial results for the year’s first quarter, showing an uptick in revenue and a net loss that shrank from the same period’s results last year.

Net sales for the three months ended March 31, 2022, totaled $1.15 billion, an increase of 4% over the amount during Q1 2021. The company reported a loss of $2 million, or 2 cents a share, down from $16 million, or 11 cents a share, in the year-ago period. Read more